SMS Lifesciences India Ltd
SMSLIFESMS Lifesciences India Ltd
SMSLIFEPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
28.81 | 1.39 | 0.17% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of organic and inorganic chemicals,pharmaceuticals
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.00 | 219.27 | 216.53 | 380.36 | 263.06 | 267.37 | 364.50 | 320.98 | 309.79 | 309.79 | ||||||||||
Raw Materials | 0.00 | 123.68 | 135.01 | 268.79 | 147.04 | 135.17 | 204.47 | 171.33 | 274.85 | 274.84 | ||||||||||
Power & Fuel Cost | 21.56 | 21.09 | 25.93 | 20.48 | 21.56 | 30.02 | 29.28 | |||||||||||||
Employee Cost | 16.89 | 17.65 | 23.11 | 26.56 | 30.66 | 39.90 | 43.43 | |||||||||||||
Selling & Administrative Expenses | 5.79 | 8.89 | 11.98 | 9.28 | 12.28 | 13.77 | 12.52 | |||||||||||||
Operating & Other expenses | 21.17 | 17.61 | 13.28 | 32.02 | 35.68 | 27.37 | 30.18 | |||||||||||||
EBITDA | 0.00 | 30.18 | 16.28 | 37.27 | 27.68 | 32.02 | 48.97 | 34.24 | 34.94 | 34.95 | ||||||||||
Depreciation/Amortization | 0.00 | 5.55 | 5.70 | 6.38 | 7.86 | 7.86 | 10.01 | 10.79 | 14.94 | 14.94 | ||||||||||
PBIT | 0.00 | 24.63 | 10.58 | 30.89 | 19.82 | 24.16 | 38.96 | 23.45 | 20.00 | 20.01 | ||||||||||
Interest & Other Items | 0.00 | 6.16 | 4.18 | 5.51 | 5.15 | 4.60 | 6.23 | 6.87 | 10.16 | 10.17 | ||||||||||
PBT | 0.00 | 18.47 | 6.40 | 25.38 | 14.67 | 19.56 | 32.73 | 16.58 | 9.84 | 9.84 | ||||||||||
Taxes & Other Items | 0.00 | 5.52 | -0.11 | 7.54 | 4.49 | 6.02 | 7.41 | 5.13 | 0.75 | 0.75 | ||||||||||
Net Income | 0.00 | 12.95 | 6.51 | 17.84 | 10.18 | 13.54 | 25.32 | 11.45 | 9.09 | 9.09 | ||||||||||
EPS | 0.00 | 12,950.00 | 42.92 | 59.01 | 33.67 | 44.79 | 83.75 | 37.87 | 30.08 | 30.07 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 1.50 | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | ||||||||||
Payout ratio | — | 0.00 | 0.00 | 0.03 | 0.00 | 0.03 | 0.02 | 0.04 | 0.05 | 0.05 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
SMS Lifesciences India Ltd | 28.81 | 1.39 | 0.17% |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare SMSLIFE with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 22, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2022
Cash Dividend
Ex DateEx DateSep 20, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2021
Cash Dividend
Ex DateEx DateSep 19, 2019
Dividend/Share
₹1.50
Ex DateEx Date
Sep 19, 2019
SMS Lifesciences India consolidated net profit rises 59.80% in the March 2022 quarter
SMS Lifesciences India divests 10% stake of wholly-owned subsidiary, Mahi Drugs
Sandur Manganese & Iron Ores Ltd leads gainers in ‘B’ group
SMS Lifesciences shares jump 20% after USFDA issues zero observation for Telangana unit
SMS Lifesciences soars after API Facility completes USFDA Inspection with No Observations
SMS Lifesciences API facility completes USFDA inspection with no observations
Top stocks in focus: Mold-Tek Packaging, GR Infraprojects, Tamilnadu PetroProducts, Deepak Nitrite, SMS Lifesciences India
SMS Lifesciences gains 5% on deal to divest partial stake in Mahi Drugs
SMS Lifesciences India to divest partial stake in Mahi Drugs; Stock dips 1%
SMS Lifesciences India Ltd leads gainers in ‘B’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -4.02%, vs industry avg of 8.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.17% to 0.08%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -12.62%, vs industry avg of 15.15%